Skip to Main Content

Paper Details

Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration-Melanoma Research Alliance Public Workshop.
Clin Cancer Res
6
2021
Melanoma, advanced unresectable, melanoma, melanomas, metastatic melanoma, participants, patient, patients, stage III melanoma
Author NameAffiliation
Donald A BerryUniversity of Texas MD Anderson Cancer Center
Caroline RobertInsitut Gustave Roussy and Paris-Saclay University
Jennifer A WargoUniversity of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2